Literature DB >> 26796504

Squamoid Eccrine Ductal Carcinoma: A Clinicopathologic Study of 30 Cases.

Michiel P J van der Horst1, Adriana Garcia-Herrera, Dorota Markiewicz, Blanca Martin, Eduardo Calonje, Thomas Brenn.   

Abstract

Squamoid eccrine ductal carcinoma is a poorly documented skin adnexal carcinoma showing squamous and duct differentiation. It is regarded to be of low-grade malignant potential, but limited follow-up information is available. To study their clinical behavior and histologic features, 30 squamoid eccrine ductal carcinomas were identified from departmental and referral files. Hematoxylin and eosin-stained sections were reviewed, and immunohistochemistry for carcinoembryonic antigen and epithelial membrane antigen was examined to confirm duct differentiation. Clinical follow-up was obtained from patient records and referring pathologists. The tumors presented as nodules or plaques (median size, 1.0 cm; range, 0.5 to 2.5 cm) with a predilection for the head and neck (77%). The patients were elderly (median age, 79.5 y; range, 10 to 96 y) with a male predominance. Histologically, these poorly demarcated tumors were characterized by an infiltrative growth pattern within the dermis and additional invasion of subcutis in 70%. Median tumor thickness was 4.3 mm (range, 1.5 to 18 mm). Superficially, the tumors resembled well-differentiated squamous cell carcinoma. In the deeper reaches, they were organized in cords and strands showing duct differentiation in a desmoplastic stroma. Cytologic atypia was moderate to severe. Ulceration (47%), necrosis (23%), and perineural and lymphovascular infiltration (27% and 6%, respectively) were additional features. Follow-up data (median, 29 mo; range, 7 to 99), available for 24 patients (80%), revealed a local recurrence rate of 25%. Three patients had lymph node metastasis, and 1 patient died of metastatic disease. Our study outlines the histologic characteristics of squamoid eccrine carcinoma and emphasizes its clinical behavior with risk for local recurrence and potential for more aggressive behavior with metastasis and rare disease-related mortality.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26796504     DOI: 10.1097/PAS.0000000000000599

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  4 in total

1.  An Unusual Morphological Presentation of Cutaneous Squamous Cell Carcinoma Mimicking Microcystic Adnexal Carcinoma: A Diagnostic Pitfall.

Authors:  Yasmine L Ibrahim; Stéphanie Lambert; Dmitry V Kazakov; Gürkan Kaya
Journal:  Dermatopathology (Basel)       Date:  2018-05-23

Review 2.  Current Diagnosis and Treatment Options for Cutaneous Adnexal Neoplasms with Apocrine and Eccrine Differentiation.

Authors:  Iga Płachta; Marcin Kleibert; Anna M Czarnecka; Mateusz Spałek; Anna Szumera-Ciećkiewicz; Piotr Rutkowski
Journal:  Int J Mol Sci       Date:  2021-05-11       Impact factor: 5.923

3.  Once in a Blue Moon … Rare Adnexal Tumor: From the Clinical and Videodermoscopical Aspects to the Mohs Surgery and the Histological Diagnosis.

Authors:  Miriam Rovesti; Francesca Satolli; Roberto Ricci; Roberta Manuguerra; Alfredo Zucchi; Marco Gandolfi; Serena Gianfaldoni; Feliciani Claudio; Uwe Wollina; Georgi Tchernev; Torello Lotti
Journal:  Open Access Maced J Med Sci       Date:  2018-01-21

4.  Dermoscopy of squamoid eccrine ductal carcinoma: an aid for early diagnosis.

Authors:  Márcio Martins Lobo-Jardim; Bruno de Castro E Souza; Priscila Kakizaki; Neusa Yurico Sakai Valente
Journal:  An Bras Dermatol       Date:  2018 Nov/Dec       Impact factor: 1.896

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.